Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Restylane Benefit Over Collagen Will Show In Data, Not Labeling Terms – CEO

This article was originally published in The Gray Sheet

Executive Summary

Pivotal trial data inclusion in Medicis/Q-Med's Restylane labeling will be sufficient to demonstrate superiority over Inamed's Zyplast, should it earn FDA approval, according to Medicis

You may also be interested in...



Inamed Stresses Hylaform Non-Inferiority; EU Clears Silicone Implant Safety

FDA's regulation of Genzyme's hyaluronic acid-based Synvisc osteoarthritic knee pain treatment could offer a precedent for labeling of the firm's Hylaform HA dermal filler

Inamed Stresses Hylaform Non-Inferiority; EU Clears Silicone Implant Safety

FDA's regulation of Genzyme's hyaluronic acid-based Synvisc osteoarthritic knee pain treatment could offer a precedent for labeling of the firm's Hylaform HA dermal filler

Facial Implant Panel Endorsement Masks Study Bias Concerns

Potential biases resulting from the use of patients as their own controls within Q-Med's Restylane pivotal trial drew criticism during FDA panel review of the hyaluronic acid-based dermal filler Nov. 21

Related Content

UsernamePublicRestriction

Register

MT019405

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel